CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
We have now added a new section called the "Assay History List" to the "At A Gla...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...